These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23709368)

  • 21. Prions and the potential transmissibility of protein misfolding diseases.
    Kraus A; Groveman BR; Caughey B
    Annu Rev Microbiol; 2013; 67():543-64. PubMed ID: 23808331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prion-like aggregates: infectious agents in human disease.
    Westermark GT; Westermark P
    Trends Mol Med; 2010 Nov; 16(11):501-7. PubMed ID: 20870462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copper-dependent functions for the prion protein.
    Brown DR; Sassoon J
    Mol Biotechnol; 2002 Oct; 22(2):165-78. PubMed ID: 12405264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prion-Like Propagation of Post-Translationally Modified Tau in Alzheimer's Disease: A Hypothesis.
    Sonawane SK; Chinnathambi S
    J Mol Neurosci; 2018 Aug; 65(4):480-490. PubMed ID: 29982964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of the maillard reaction to prion protein aggregation.
    Panza G; Dumpitak C; Birkmann E
    Rejuvenation Res; 2010; 13(2-3):220-3. PubMed ID: 20370497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies.
    Beekes M; McBride PA
    FEBS J; 2007 Feb; 274(3):588-605. PubMed ID: 17288548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generalizing a mathematical model of prion aggregation allows strain coexistence and co-stability by including a novel misfolded species.
    Lemarre P; Pujo-Menjouet L; Sindi SS
    J Math Biol; 2019 Jan; 78(1-2):465-495. PubMed ID: 30116882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Prion 2018 round tables (II): Aβ, tau, α-synuclein… are they prions, prion-like proteins, or what?
    Eraña H
    Prion; 2019 Jan; 13(1):41-45. PubMed ID: 30646820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious prion diseases in humans: cannibalism, iatrogenicity and zoonoses.
    Haïk S; Brandel JP
    Infect Genet Evol; 2014 Aug; 26():303-12. PubMed ID: 24956437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prion-Like Protein Aggregates and Type 2 Diabetes.
    Mukherjee A; Soto C
    Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28159831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The highways and byways of prion protein trafficking.
    Campana V; Sarnataro D; Zurzolo C
    Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
    Victoria GS; Zurzolo C
    J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurodegenerative diseases: expanding the prion concept.
    Walker LC; Jucker M
    Annu Rev Neurosci; 2015 Jul; 38():87-103. PubMed ID: 25840008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prion diseases of humans and animals: their causes and molecular basis.
    Collinge J
    Annu Rev Neurosci; 2001; 24():519-50. PubMed ID: 11283320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggregation and amyloid fibril formation of the prion protein is accelerated in the presence of glycogen.
    Panza G; Stöhr J; Birkmann E; Riesner D; Willbold D; Baba O; Terashima T; Dumpitak C
    Rejuvenation Res; 2008 Apr; 11(2):365-9. PubMed ID: 18341429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prions: protein aggregation and infectious diseases.
    Aguzzi A; Calella AM
    Physiol Rev; 2009 Oct; 89(4):1105-52. PubMed ID: 19789378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.